Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiki Niimi

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
FEBS Open Bio|February 22, 2023
Sphingolipid abnormalities in encephalomyeloradiculoneuropathy (EMRN) are associated with an anti-neutral glycolipid antibodyTatsuro Mutoh, Akihiro Ueda, Yoshiki Niimi
Geriatrics & Gerontology International|September 4, 2022
Change in long-term care service usage in Japan following the COVID-19 pandemic: A survey using a nationwide statistical summary in 2018-2021Kenichiro Sato, Yoshiki Niimi, Takeshi Iwatsubo, et al.
Brain and Nerve = Shinkei Kenkyu No Shinpo|June 26, 2007
[An autopsy case of cryptococcal meningoencephalitis with AIDS: correspondence between MRI and pathological findings of basal ganglia and cerebellum]Toshitaka Umemura, Mikio Hirayama, Yoshiki Niimi, et al.
Journal of Alzheimer'S Disease Reports|September 4, 2025
Cost-benefit of dementia insurance for cognitively-unimpaired <i>APOE</i> ε4 homozygotes: A simulation studyKenichiro Sato, Saki Nakashima, Yoshiki Niimi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthSaki Nakashima, Kenichiro Sato, Yoshiki Niimi, et al.
JAR Life|March 21, 2025
Factors affecting participation in web-based Alzheimer's questionnaire surveys: Lessons from the Japanese trial-ready cohortSaki Nakashima, Kenichiro Sato, Yoshiki Niimi, et al.
JAR Life|July 30, 2025
How many sites are enough? a novel, site-based power analysis method for real-world registry studies of anti-amyloid monoclonal antibodiesKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Mapping U.S. POINTER Cognitive-Slope Gains Onto Predicted Clinical Progression: An External-Cohort Translation Analysis With Exploratory Economic ThresholdsSaki Nakashima, Kenichiro Sato, Yoshiki Niimi, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 15, 2023
[Survey on the Current Advertising and Sales of Mucuna pruriens in Consumer-to-consumer Internet Trading in Japan]Kenichiro Sato, Ayumi Hida, Yoshiki Niimi, et al.
Frontiers in Neurology|May 20, 2022
Automated Evaluation of Conventional Clock-Drawing Test Using Deep Neural Network: Potential as a Mass Screening Tool to Detect Individuals With Cognitive DeclineKenichiro Sato, Yoshiki Niimi, Tatsuo Mano, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
FEBS Open Bio|February 22, 2023
Sphingolipid abnormalities in encephalomyeloradiculoneuropathy (EMRN) are associated with an anti-neutral glycolipid antibodyTatsuro Mutoh, Akihiro Ueda, Yoshiki Niimi
Geriatrics & Gerontology International|September 4, 2022
Change in long-term care service usage in Japan following the COVID-19 pandemic: A survey using a nationwide statistical summary in 2018-2021Kenichiro Sato, Yoshiki Niimi, Takeshi Iwatsubo, et al.
Brain and Nerve = Shinkei Kenkyu No Shinpo|June 26, 2007
[An autopsy case of cryptococcal meningoencephalitis with AIDS: correspondence between MRI and pathological findings of basal ganglia and cerebellum]Toshitaka Umemura, Mikio Hirayama, Yoshiki Niimi, et al.
Journal of Alzheimer'S Disease Reports|September 4, 2025
Cost-benefit of dementia insurance for cognitively-unimpaired <i>APOE</i> ε4 homozygotes: A simulation studyKenichiro Sato, Saki Nakashima, Yoshiki Niimi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthSaki Nakashima, Kenichiro Sato, Yoshiki Niimi, et al.
JAR Life|March 21, 2025
Factors affecting participation in web-based Alzheimer's questionnaire surveys: Lessons from the Japanese trial-ready cohortSaki Nakashima, Kenichiro Sato, Yoshiki Niimi, et al.
JAR Life|July 30, 2025
How many sites are enough? a novel, site-based power analysis method for real-world registry studies of anti-amyloid monoclonal antibodiesKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Mapping U.S. POINTER Cognitive-Slope Gains Onto Predicted Clinical Progression: An External-Cohort Translation Analysis With Exploratory Economic ThresholdsSaki Nakashima, Kenichiro Sato, Yoshiki Niimi, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 15, 2023
[Survey on the Current Advertising and Sales of Mucuna pruriens in Consumer-to-consumer Internet Trading in Japan]Kenichiro Sato, Ayumi Hida, Yoshiki Niimi, et al.
Frontiers in Neurology|May 20, 2022
Automated Evaluation of Conventional Clock-Drawing Test Using Deep Neural Network: Potential as a Mass Screening Tool to Detect Individuals With Cognitive DeclineKenichiro Sato, Yoshiki Niimi, Tatsuo Mano, et al.
Pageof 8